Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- 47 Chemotherapy Specialists to Be Certified by JSMO in April
March 6, 2006
- Chugai Licenses Conditionally Immortalized Cell Line from Cambrex
March 6, 2006
- NEW BOOKS
March 6, 2006
- Kyowa Hakko Licenses Parkinson's Treatment from Britannia
March 6, 2006
- Japanese Branch of RAPS Established
March 6, 2006
- Bayer Yakuhin to Create Anticancer Drug Division
March 6, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
March 6, 2006
- Femara to Drive Growth of Novartis Pharma
March 6, 2006
- STATSUTICS
March 6, 2006
- MediciNova to Out-license 1st Product This Year: Dr Iwaki
March 6, 2006
- BUSINESS NEWS IN BRIEF
March 6, 2006
- Systems Drug Discovery Should Replace Probabilistic Drug Discovery: Prof. Tanuma
February 27, 2006
- BUSINESS NEWS IN BRIEF
February 27, 2006
- AstraZeneca Starts IPAS Study on Iressa to Verify Efficacy in Orientals
February 27, 2006
- Toho to Focus on Quality of Services, Not Share: President Hamada
February 27, 2006
- Takeda Licenses Hematide from Affymax
February 27, 2006
- Replidyne, Forest to Comarket Faropenem Medoximil: Daiichi Asubio
February 27, 2006
- Kyorin Licenses KRP-203 to Novartis
February 27, 2006
- SURVEY 4 articles
February 27, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 27, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…